Martine A. Rothblatt Sells 3,600 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the stock in a transaction dated Friday, July 12th. The stock was sold at an average price of $324.97, for a total transaction of $1,169,892.00. Following the sale, the chief executive officer now owns 130 shares of the company’s […]

Leave a Reply

Your email address will not be published.

Previous post Pinnacle Financial Partners, Inc. (NASDAQ:PNFP) Receives Consensus Rating of “Moderate Buy” from Brokerages
Next post Belgium June 2024: MG breaks volume record